The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Even manado keeps repeating his posts on the other side. Buying at 11p proved to be throwing good money after bad. And folks were queuing , it’s not under value , it’s exactly where it should be
Every little helps , DNA based vaccine with less than 10% of complete response and on average efficacy increment from 18% to 30% in comparison to Keytruda on its own. Will be interesting go to compare to SC results when published.
Rat, makes perfect sense , we must be getting RNS 2moro or in the very near future. Due to the magnitude of the event and the slot allocation it wouldn’t be unreasonable to expect top mark results which may be unique to Scancell game changer technology.